Meperidine for Patients Expected to Have Poor Tolerance During Diagnostic Esophagogastroduodenoscopy.
Status:
Completed
Trial end date:
2017-03-01
Target enrollment:
Participant gender:
Summary
Our pilot results showed that meperidine reduce patient discomfort during EGD
(esophagogastroduodenoscopy). But many patients can tolerate EGD well without any sedative
agents. So the investigators target the use of meperidine on patients expected to have poor
tolerance in this study, which includ young females with high anxiety level and patients with
prior poor tolerance. The investigators test the hypothesis that meperidine improves
tolerance and alleviates discomfort for patients expected to have poor tolerance during
diagnostic EGD.